Twist Bioscience Corporation (TWST)

Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	201.37	226.32	286.47	378.69	465.83	93.67
Short-Term Investments	49.43	50.08	49.94	126.28	12.03	196.34
Cash & Short-Term Investments	250.8	276.4	336.41	504.97	477.86	290
Cash Growth	-13.34%	-17.84%	-33.38%	5.67%	64.78%	109.98%
Accounts Receivable	49.85	34.9	44.06	40.29	26.21	25.43
Other Receivables	1.2	-	-	-	2.34	0.95
Receivables	51.05	34.9	44.06	40.29	28.55	26.38
Inventory	25.94	24.08	32.06	39.31	31.8	12.29
Prepaid Expenses	11.99	11.4	11.72	11.91	8.28	6.2
Total Current Assets	339.78	346.78	424.26	596.48	546.5	334.87
Property, Plant & Equipment	147.2	161.35	203.36	214.39	105.7	59.17
Goodwill	82.2	85.81	85.81	85.81	22.43	1.14
Other Intangible Assets	13.69	14.48	54.48	59.74	18.26	0.31
Other Long-Term Assets	4.71	5.91	8.49	4.96	6.18	3.4
Total Assets	643.61	614.32	776.4	961.38	702.1	398.88
Accounts Payable	11.99	1.63	14.05	20.09	14.9	4.83
Accrued Expenses	48.51	48.75	36.57	37.19	28.76	18.85
Current Portion of Long-Term Debt	-	-	-	-	1.55	3.33
Current Portion of Leases	15.5	14.81	14.9	13.64	8.21	6.41
Current Income Taxes Payable	4.25	2.73	4.37	3.66	2.44	0.72
Current Unearned Revenue	6.32	2.13	3	3.48	1.09	-
Other Current Liabilities	0.5	0.96	0.43	12.6	6.1	1.89
Total Current Liabilities	87.07	71.01	73.32	90.66	63.05	36.03
Long-Term Debt	15	-	-	-	-	1.4
Long-Term Leases	62.65	70.22	79.17	81.27	53.16	24.84
Other Long-Term Liabilities	0.69	0.41	0.48	0.06	5.07	0.35
Total Liabilities	165.41	141.63	152.97	171.99	121.28	62.62
Additional Paid-In Capital	1,772	1,715	1,657	1,620	1,191	794.63
Retained Earnings	-1,292	-1,242	-1,033	-828.42	-610.55	-458.46
Comprehensive Income & Other	-0.86	-0.52	-0.76	-1.84	0.55	0.09
Total Common Equity	478.2	472.69	623.43	789.39	580.82	336.26
Shareholders' Equity	478.2	472.69	623.43	789.39	580.82	336.26
Total Liabilities & Equity	643.61	614.32	776.4	961.38	702.1	398.88
Total Debt	93.15	85.03	94.07	94.91	62.92	35.98
Net Cash (Debt)	157.65	191.37	242.34	410.06	414.94	254.02
Net Cash Growth	-22.05%	-21.03%	-40.90%	-1.18%	63.35%	94.84%
Net Cash Per Share	2.66	3.30	4.26	7.61	8.60	6.48
Filing Date Shares Outstanding	60.36	59.36	57.67	56.57	49.63	45.15
Total Common Shares Outstanding	60.17	58.88	57.56	56.52	49.5	45.08
Working Capital	252.71	275.77	350.93	505.82	483.44	298.84
Book Value Per Share	7.95	8.03	10.83	13.97	11.73	7.46
Tangible Book Value	382.32	372.4	483.14	643.84	540.13	334.82
Tangible Book Value Per Share	6.35	6.33	8.39	11.39	10.91	7.43
Machinery	102.76	105.93	111.18	67.43	53.61	41.9
Construction In Progress	13.33	4.69	8.53	87.72	16.97	4.7
Leasehold Improvements	58.27	57.45	57.27	14.37	5.07	4.67

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q